Indication
Muscle weakness in Barth syndrome
Muscle weakness in Barth syndrome is a clinical manifestation of the underlying skeletal myopathy that characteristically affects hemizygous males with this rare, X-linked mitochondrial condition. Read more about Muscle weakness in Barth syndrome
2 drugs 2 manufacturers
Drugs that treat it
Common Muscle weakness in Barth syndrome therapies.
FORZINITY (elamipretide HCl)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonMuscle weakness in Barth syndrome is a clinical manifestation of the underlying skeletal myopathy that characteristically affects hemizygous males with this rare, X-linked mitochondrial condition.
Pathophysiologically, it stems from pathogenic variants in the *TAFAZZIN* gene, which disrupt cardiolipin remodeling in the inner mitochondrial membrane, impairing cellular respiratory chain function and skeletal muscle bioenergetics.
Clinically, affected individuals typically demonstrate generalized hypotonia from infancy, reduced muscle bulk, and predominantly proximal muscle weakness.
This impairment contributes to delayed early motor milestone achievement, diminished physical stamina, and severe exercise intolerance that persists into adulthood.
- nih.gov
Muscle weakness in Barth syndrome is a clinical manifestation of the underlying skeletal myopathy that characteristically affects hemizygous males with this rare, X-linked mitochondrial condition Clinically, affected individuals typically demonstrate generalized hypotonia from infancy, reduced muscle bulk, and predominantly proximal muscle weakness
- kennedykrieger.org
Muscle weakness in Barth syndrome is a clinical manifestation of the underlying skeletal myopathy that characteristically affects hemizygous males with this rare, X-linked mitochondrial condition
- medlink.com
Pathophysiologically, it stems from pathogenic variants in the *TAFAZZIN* gene, which disrupt cardiolipin remodeling in the inner mitochondrial membrane, impairing cellular respiratory chain function and skeletal muscle bioenergetics
- umdf.org
Pathophysiologically, it stems from pathogenic variants in the *TAFAZZIN* gene, which disrupt cardiolipin remodeling in the inner mitochondrial membrane, impairing cellular respiratory chain function and skeletal muscle bioenergetics
- medlineplus.gov
Clinically, affected individuals typically demonstrate generalized hypotonia from infancy, reduced muscle bulk, and predominantly proximal muscle weakness This impairment contributes to delayed early motor milestone achievement, diminished physical stamina, and severe exercise intolerance that persists into adulthood
- nih.gov
Clinically, affected individuals typically demonstrate generalized hypotonia from infancy, reduced muscle bulk, and predominantly proximal muscle weakness This impairment contributes to delayed early motor milestone achievement, diminished physical stamina, and severe exercise intolerance that persists into adulthood
- nih.gov
This impairment contributes to delayed early motor milestone achievement, diminished physical stamina, and severe exercise intolerance that persists into adulthood
Personalize your experience
Follow Muscle weakness in Barth syndrome and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.